On September 17, 2019, IDL Biotech will launch the company’s rapid test for typhoid fever, TUBEX TF, in Kenya.
Read more here

On September 17, 2019, IDL Biotech will launch the company’s rapid test for typhoid fever, TUBEX TF, in Kenya.
Read more here
During a recent visit to KSB Biotech in China, IDL Diagnostics and its German partner concile explored potential additions to Concile Global’s international point-of-care testing portfolio. Discussions focused on biomarkers compatible with the reader platforms already...
IDL Diagnostics recently met with CLIA partner Zecen, and its Chinese distributors Vastec, Sysmex and Fosun, to discuss market opportunities and portfolio development. Discussions highlighted China’s national pricing-code framework, expected to be implemented by the...
CEO Gustav Sten and CFO Ellen Dittberner present the company’s Q3’26 results – November 5, 2026